Tag: non-invasive neuromodulation
NeuraLace announces two new patents for Axon neuropathic pain therapies
NeuraLace Medical has announced the expansion of its global patent portfolio with the issuance of two new patents: US Patent No. 11,305,130 for "Devices, systems,...
Neuromodulation device for treating MS-related gait deficit receives FDA authorisation
Cambridge Consultants and Helius Medical Technologies have confirmed their “groundbreaking" Portable Neuromodulation Stimulator (PoNS) device—developed for the short-term treatment of gait deficit due to...
rTMS found to be “well-accepted” for therapeutic use in psychiatric populations
Psychiatric populations perceive the therapeutic use of repetitive transcranial magnetic stimulation (rTMS) for mental health conditions to be beneficial, safe, and no more dangerous...
MagVenture introduces MagVenture Flow Arm use in non-invasive brain stimulation
MagVenture has introduced the MagVenture Flow Arm — a patent-pending, clinical positioning system to optimise the delivery of MagVenture's FDA cleared protocols for non-invasive...
New study shows improvement in opioid withdrawal symptoms through non-invasive neuromodulation
A late-breaking abstract presented at the North American Neuromodulation Society (NANS) 2021 virtual meeting (January 15–16) has shown that non-invasive neuromodulation may present a...
